Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER1 | P34995 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29761900 | 1.00 | PTGER1 (1.00) | PTGER1 | |
| Hydrochloric Acid SCHEMBL4104578 | 0.99 | PTGER1 (1.00) | PTGER1 | |
| SCHEMBL13693324 | 0.95 | PTGER1 (0.98) | PTGER1 | |
| Hydrochloric Acid SCHEMBL4096755 | 0.95 | PTGER1 (1.00) | PTGER1 | |
| SCHEMBL3056778 | 0.91 | PTGER1 (0.84) | PTGER1 | |
| Hydrochloric Acid SCHEMBL3056914 | 0.90 | PTGER1 (0.84) | PTGER1 | |
| SCHEMBL3578834 | 0.90 | PTGER1 (0.81) | PTGER1 | |
| SCHEMBL3058104 | 0.90 | PTGER1 (0.81) | PTGER1 | |
| Hydrochloric Acid SCHEMBL3049776 | 0.89 | PTGER1 (0.82) | PTGER1 | |
| Hydrochloric Acid SCHEMBL3583126 | 0.89 | PTGER1 (0.82) | PTGER1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090239845-A1 | PYRAZOLE COMPOUNDS AS PROSTAGLANDIN RECEPTORS LIGANDS | CONWAY ELIZABETH ANN | 2009-09-24 | — | — | US | claimed |
| US-20180153830-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2018-06-07 | — | — | US | disclosed |
| US-20180153830-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2018-06-07 | — | — | US | disclosed |
| US-20170027890-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2017-02-02 | — | — | US | disclosed |
| US-20170027890-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2017-02-02 | — | — | US | disclosed |
| US-20170027890-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2017-02-02 | — | — | US | disclosed |
| US-9456998-B2 | Selective inhibitors of undifferentiated cells | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2016-10-04 | — | — | US | disclosed |
| US-9456998-B2 | Selective inhibitors of undifferentiated cells | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2016-10-04 | — | — | US | disclosed |
| US-9456998-B2 | Selective inhibitors of undifferentiated cells | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2016-10-04 | — | — | US | disclosed |
| CN-104768549-A | Selective inhibitors of undifferentiated cells | YISSUM RES DEV CO | 2015-07-08 | — | — | CN | disclosed |
| US-20150148359-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2015-05-28 | — | — | US | disclosed |
| US-20150148359-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2015-05-28 | — | — | US | disclosed |
| US-20150148359-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2015-05-28 | — | — | US | disclosed |
| EP-2852387-A2 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2015-04-01 | — | — | EP | disclosed |
| WO-2013175474-A2 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2013-11-28 | — | — | WO | disclosed |
| WO-2013175474-A2 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2013-11-28 | — | — | WO | disclosed |
| US-20090239845-A1 | PYRAZOLE COMPOUNDS AS PROSTAGLANDIN RECEPTORS LIGANDS | CONWAY ELIZABETH ANN | 2009-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090239845-A1 | PYRAZOLE COMPOUNDS AS PROSTAGLANDIN RECEPTORS LIGANDS | PTGER1, PTGDR, PTGIR | PTGER1 1/4885 |
| US-20180153830-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | MCL1, MKI67, SCD | PTGER1 732/4885 |
| US-20170027890-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | MCL1, MKI67, SCD | PTGER1 732/4885 |
| US-20150148359-A1 | SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS | MCL1, MKI67, SCD | PTGER1 732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.